These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1563378)

  • 1. Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients.
    Jonsson M; Walder M
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):15-21. PubMed ID: 1563378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Pharmacol; 1988; 34(2):179-86. PubMed ID: 3289950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ceftazidime in sheep and its penetration into tissue and peritoneal fluids.
    Rule R; Rubio M; Perelli MC
    Res Vet Sci; 1991 Nov; 51(3):233-8. PubMed ID: 1780573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers.
    Wise ER; Armstrong GC; Brown RM; Andrews JM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():277-82. PubMed ID: 19802998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ceftazidime administered to lactating and non-lactating goats.
    Rule R; Villagra S; Barrena P; Lacchini R; Reynaldi FJ
    J S Afr Vet Assoc; 2011 Dec; 82(4):219-23. PubMed ID: 22616435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ceftazidime in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular injections.
    Stamper MA; Papich MG; Lewbart GA; May SB; Plummer DD; Stoskopf MK
    J Zoo Wildl Med; 1999 Mar; 30(1):32-5. PubMed ID: 10367641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of ceftazidime in lactating and non-lactating cows.
    Rule R; Quiroga GH; Rubio M; Buschiazzo HO; Buschiazzo PM
    Vet Res Commun; 1996; 20(6):543-50. PubMed ID: 8950835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Pharmacol; 1988; 34(2):173-8. PubMed ID: 3289949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis.
    Demotes-Mainard F; Vinçon G; Ragnaud JM; Morlat P; Bannwarth B; Dangoumau J
    J Clin Pharmacol; 1993 May; 33(5):475-9. PubMed ID: 8331207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.
    Walstad RA; Aanderud L; Thurmann-Nielsen E
    Eur J Clin Pharmacol; 1988; 35(5):543-9. PubMed ID: 3069478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
    Albarellos GA; Ambros LA; Landoni MF
    Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
    Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ceftazidime in febrile neutropenic patients.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 2001; 33(3):222-6. PubMed ID: 11303815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing age and acute infection influence the kinetics of ceftazidime.
    Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 1989; 21(3):327-32. PubMed ID: 2667099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 May; 49(5):445-52. PubMed ID: 10792202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients.
    Traunmüller F; Schenk P; Mittermeyer C; Thalhammer-Scherrer R; Ratheiser K; Thalhammer F
    J Antimicrob Chemother; 2002 Jan; 49(1):129-34. PubMed ID: 11751776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum and cerebrospinal fluid kinetics of ceftazidime].
    Nadstawek J; Weil HP; Frenkel C; Kühnen E; Mauersberger W; Hörnchen U
    Immun Infekt; 1989 Dec; 17(6):212-6. PubMed ID: 2693344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related characteristics of ceftazidime pharmacokinetics in children].
    Prokhorenko PI; Strachunskiĭ LS; Andreenkova EG; Portnoĭ IuA; Firsov AA
    Antibiot Khimioter; 1992 Jun; 37(6):29-31. PubMed ID: 1417341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.